Nicolet Bankshares Inc Abb Vie Inc. Transaction History

Nicolet Bankshares Inc

$480 Million
Q1 2024

A detailed history of Nicolet Bankshares Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Nicolet Bankshares Inc holds 5,437 shares of ABBV stock, worth $958,053. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,437

Previous 5,403 0.63%

Holding current value

$958,053

Previous $837,000 18.28%

% of portfolio

0.21%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $5,433 - $6,191	34 Added 0.63%	5,437 $990,000
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $52,012 - $58,578	378 Added 7.52%	5,403 $837,000
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $131,052 - $163,086	-989 Reduced 16.44%	5,025 $677,000
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $121,038 - $139,393	837 Added 16.17%	6,014 $958,000
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $68,878 - $82,603	-498 Reduced 8.78%	5,177 $837,000

Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $55,160 - $63,265	-411 Reduced 6.75%	5,675 $762,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $52,295 - $66,484	380 Added 6.66%	6,086 $932,000
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $111,259 - $138,041	843 Added 17.33%	5,706 $925,000
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $206,522 - $234,433	-1,941 Reduced 28.53%	4,863 $525,000
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $36,823 - $41,023	-350 Reduced 4.89%	6,804 $766,000
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $182,298 - $200,688	1,782 Added 33.17%	7,154 $774,000
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $3,461 - $4,672	-43 Reduced 0.79%	5,372 $576,000
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $68,298 - $80,159	795 Added 17.21%	5,415 $474,000
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $26,853 - $35,933	366 Added 8.6%	4,620 $454,000
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $2,885 - $3,610	40 Added 0.95%	4,254 $377,000
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $67,766 - $81,474	-1,076 Reduced 20.34%	4,214 $319,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $17,410 - $22,254	265 Added 5.27%	5,290 $385,000
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $1,002 - $1,180	13 Added 0.26%	5,025 $405,000
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $18,048 - $20,064	203 Added 4.22%	5,012 $474,000
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $19,302 - $22,839	215 Added 4.68%	4,809 $446,000
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $644 - $862	-7 Reduced 0.15%	4,594 $435,000
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $3,582 - $3,928	-40 Reduced 0.86%	4,601 $445,000
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $324,173 - $414,070	4,641	4,641 $412,000

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Bankshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Bankshares Inc with notifications on news.

Account

Nicolet Bankshares Inc Abb Vie Inc. Transaction History